A series of N-methyl-diarylamines 2 was designed and synthesized as a novel class of CA-4 and isoCA-4 analogues.
Introduction
Combretastatin A-4 (CA-4) a natural stilbene isolated from the African willow tree, Combretum caffrum in 1989 by Pettit [1] has been found to be a potent anticancer agent which strongly inhibits tubulin assembly by binding to the colchicine site. [2] CA-4 also shows potent cytotoxicity against a wide range of human cancer cell lines including multi drugs resistant (MDR) cancer cells. [3] Moreover, CA-4 has been demonstrated to selectively target the vascular network of tumors, inducing irreversible shutdown of blood flow to neoplastic cells. [4] Currently, two water-soluble prodrug derivatives are in clinical trials: disodium phosphate CA-4P (fosbretabulin, Zybrestat TM ) [5] and AVE8062 (ombrabulin). [6] To date, CA-4P [7, 8] either as a single agent or in combination therapy is undergoing several advanced clinical trials worldwide for the treatment of age-related macular degeneration or anaplastic thyroid cancer. Despite their remarkable anticancer properties, the main problem associated with CA-4 and its prodrugs is the ready isomerization of the Z-double bond into the inactive E-form during storage, administration and metabolism. [9, 10] In an ongoing project aimed at developing stable CA-4 analogues [11, 12, 13, 14, 15, 16, 17, 18, 19] , we recently solved the stability problem of CA-4 by the discovery of the non-isomerizable isocombretastatin A-4 (isoCA-4) which holds biological activities comparable to that of CA-4. [20, 21] . This structural isomer of the natural product, having a 1,1diarylethylene scaffold, is chemically and metabolically stable [22] and easy to synthesize [23, 24, 25] at a multigrams scale without the need to control the olefin geometry. By chemical modifications on the B-ring of isoCA-4, we have also identified other stable and promising antiproliferative agents [21, 26] such as isoNH2CA-4 and isoFCA- 4 . We next have demonstrated that the reduction of the 1,1-ethylene bond of isoCA-4 led to (±)-isoerianin, in which racemic and both enantiomers displayed excellent anti-cancer activities comparable to that of the natural isomer erianin. [27] It seems that the carbon (Csp 3 ) linker in isoerianin is not involved in the interaction in the colchicine binding site. It serves only to position correctly the two aromatic rings of the molecule [27] . Herein, we planned to prepare a new class of isoerianin derivatives, named azaisoerianins (Figure 1 ), in which the two aromatic rings are connected through a nitrogen atom in place of the carbon linker in isoerianin compounds. Indeed, the diphenylamine skeleton is a common privileged structure found in biologically active compounds, and compounds derived from this scaffold manifest diverse activities, including anticancer activity. [28, 29] This design has several advantages as follow: (i) the ease in synthesis where various side-arms can be introduced on nitrogen atom in a convergent access, (ii) the absence of a chiral center, (iii) the rapid access to weakly basic and chargeable derivatives in a solubilization strategy, (iv) the discovery of a third generation of candidates having promising antiproliferative and antitubulin activities and a better understanding of structure-activity relationships (SAR). In this article are described the synthesis and the biological evaluation of novel azaisoerianin derivatives 2 and 3. Preliminary in vitro efficacy of these compounds in terms of cytotoxicity, inhibition of tubulin assembly, cell cycle, apoptosis and in vitro antivascular activity is described. The possible binding mode of the most bioactive substrates 2b and 2m on tubulin is also reported. The synthesis of azaisoerianin derivatives 2a-q and 3a-c, is summarized in Scheme 1. Diarylanilines 1a-l were prepared from commercially available methoxylated anilines which were coupled in a sealed tube with a variety of aryl and heteroaryl halides under our previously reported conditions (Pd(OAc)2 as the catalyst, Xantphos as the ligand, Cs2CO3 as the base in hot dioxane). [30, 31, 32, 33] Treatment of the resulting diarylamines 1 with sodium hydride followed by reaction with MeI gave the best results for the N-alkylation process furnishing the desired trisubstituted amines 2. By analogy with highly cytotoxic N-propylbenzylanilines, [34] N-propyl derivatives 3 were prepared using a large excess of nPrBr as the alkylating agent and NaH as the base. Reduction of the nitro group of 2c using HCl and iron powder yielded azasoerianin derivative 2d with 3-amino-4-methoxy groups on the B-ring similar to the B-ring of AVE8062 drug. Debenzylation of the phenol function of 2f was carried out by hydrogenation to afford azaisoerianin 2g having the greatest resemblance with isoerianin and isoCA-4. Compound 2j was synthesized from 4-chloro derivative 2i using dimethylamine in the presence of Pd2(dba)3.CHCl3 (5 mol%), and Johnphos (10 mol%) as the ligand and tBuONa as the base in hot toluene. [35] Finally, the removal of the N-protected tosyl group of 2p was accomplished by the use of TBAF in DMF at 100 °C to afford 2q (49%).
Results and discussion

Biological results.
New synthesized azaisoerianin compounds were evaluated for their cytotoxic effects against HCT116 human carcinoma cell line and for tubulin polymerization inhibitory activity. Isoerianin [27] , isoCA-4 [21] and CA-4 [36] were included as reference compounds. The cytotoxicity and inhibition of tubulin polymerization (ITP) results are presented in Table   1 . Without any exception, all secondary diarylamines 1 were not cytotoxic (data not shown). In the series of compounds 2 having a benzene substituted B-ring, our findings showed that compound 2b, having a fluorine atom at the C3'-position, displayed the best cytotoxicity with a GI50 values of 20 nM comparable to that of the reference isoerianin. Additionally, the water-soluble hydrochloride salt 2b-HCl displayed a high level of cytotoxicity against HCT116 cells (GI50 = 28 nM) comparable to that of the parent molecule 2b (GI50 = 22 nM). Replacement of the F atom with H or a NH2 on the C3'-position generated compounds 2a and 2d (GI50 = 64 nM and 66 nM, respectively) which were three fold less active than 2b. Contrary to our expectations, a dramatic loss of antiproliferative activity was observed with azaisoerianin 2g, having a OH group on C3'-position.This compound and its corresponding acetate 2h displayed only modest cytotoxicity against HCT116 cells (GI50 = 650-700 nM). We next showed that the introduction of a pyridine or a quinoline nucleus as B-ring resulted in products 2k (GI50 = 650 nM) and 2l (GI50 = 2100 nM), respectively, with a significant loss of potency. We next investigated the role on cytotoxicity of derivatives having an indole nucleus which was found useful as B-ring in the CA-4 series. [37] It is significant to note that in the azaisoerianin series, N-methyl-indol-5-yl compound 2m was consistently the more potent compound. This lead compound (2m) was about four times more cytotoxic than the reference isoerianin with a low GI50 value of 7 nM. The absence of the trimethoxyphenyl-ring in the 5-indoyl series reduced the cytotoxicity as it was observed with compounds 2n (GI50 = To investigate whether compounds 2 and 3 exert their activities by interacting with microtubules, their effect on the in vitro polymerization of purified tubulin was next examined (see Table 1 ). It is of interest to note that highly cytotoxic derivatives 2b and N-methylindole 2m were also very potent as tubulin inhibitors and were comparable to isoerianin with IC50 micromolar values (2.7 M and 1.3 M for 2b and 2m, respectively). Interestingly, derivative 2g, having the greatest resemblance to isoCA-4 and isoerianin which was poorly cytotoxicity against HCT116 cells was one of the more potent agent as tubulin inhibitor with an IC50 value of 1.5 M. Similarly, N-propyl derivatives 3b and 3c which displayed a modest level of cytotoxicity were very potent in the tubulin assay with IC50 values ranging from 2.8 to 3.6
M.
These results showed an important discrepancy between the potency of antitubulin activity and cytotoxicity of N-propyl derivatives 3, indicating that with hindered substituents on the nitrogen atom of derivatives 3, it might be possible to design news series of antivascular agents with low cytoxicity.
To gain further insight the mechanism of action of azaisoerianin derivatives 2, the most cytotoxic compounds 2b and 2m were assayed for their effects on cell cycle distribution. K562 and HCT116 cells were treated with 2b and 2m at different concentrations for 24 h. The results presented in Figure 2 , demonstrate that there was an accumulation of K562 and HCT116 cells in the G2/M phase of the cellular cycle after treatment with 2b and 2m at very low concentrations.
One note that there is a better perturbation of cycle cell progression in K562 cells after treatment with these drugs, and indolic derivative 2m seems to be slightly more effective than 2b in K562 and HCT116 cells. DNA content
The ability of 2b and 2m to induce apoptosis in HCT116 cells was further characterized using caspase-3 and caspase-7 assays. The enzymatic activity of these caspases was measured by monitoring the cleavage of the fluorogenic substrate Z-DEVD-R110 in cancer cells. The results presented in Table 3 show a significant dose-dependent increase in proteolytic activity of caspases in the cells treated for 24 h with diarylmethylamines 2b and 2m. A spectacular 4-fold increase in apoptosis was evidenced by 2m in HCT116 cells at a low concentration of 7.5 nM. These results indicate that, in addition to their antiproliferative and antitubulin effects, the treatment of cancer cells with 2b and 2m activate caspases system leading to programmed cell death. To identify compounds that disrupt the neovascularization formation, an assay using endothelial colony-forming cells (ECFCs) was performed with a panel of diarylamines 2 and 3. In the presence of the vascular endothelial growth factor (VEGF), ECFCs form tube-like structures that express the endothelial marker (CD31) when co-cultured on an ADSC feeder layer. [38] The inhibition of endothelial tube formation (IC50) was determined after 96 h of treatment using ECFCs, VEGF and compounds 2a-b, 2d and 2m as angiogenesis inhibitors. isoCA- 4 7 These results were next confirmed by a second in vitro model of angiogenesis [39] in which human umbilical vein endothelial cells (HUVECs), when seeded on Matrigel TM , aggregate to form a reticular vascular network of capillarylike vessels. The results presented in Table 2 (see above) revealed that after 72 h of incubation, 2b and 2m exhibited good growth inhibition activity against HUVEC cells with GI50 values of 22 and 7 nM, respectively. To evaluate whether 2b and 2m could affect models of newly formed blood vessels, the HUVEC tube disruption assay was performed. Addition of 2b at a concentration of 10 nM, and more significantly at 100 nM, rapidly disrupted the integrity of the network (Figure 3 ). This effect was visible after only 3 h of treatment at doses of 10 and 100 nM which were not cytotoxic for such incubation time (data not shown). This antivascular effect is even more pronounced with indole derivative 2m which destroyed neovascularization at a very low dose of 5 nM. All together these results suggested that azaisoserianin derivatives 2, and particularly 2m and 2b, might be considered and evaluated as vascular disrupting agents for further in vivo studies.
Docking study.
The biological IPT and antivascular results demonstrated that tubulin is the target of these diarylamines 2 and 3.
Molecular docking calculations were performed with 2b and 2m in order to investigate their possible binding mode in the colchicine binding site of tubulin. For this purpose, the X-ray structure of tubulin DAMA-colchicine complex (accession code 1SA0) [40] was used. Figure 4 illustrates the docking-derived superimposition of 2b and 2m, with isoCA-4 (green). As expected, these diarylamines showed a binding pose matching the one calculated under the same conditions for isoCA-4, used as a reference compound with its A-trimethoxyphenyl ring placed in the proximity of Cys241. Additionally, the 4′-OMe substituent of 2b accepts a stabilizing H-bond donated by a polar hydrogen atom belonging to the side-chain amide moiety of Asn101. Superimposition of 2b (pink) and isoCA-4 (green) Superimposition of 2m (pink) and isoCA-4 (green)
Conclusions
We designed and synthesized a series of original N-methyl-and N-propyldiarylamines 2 and 3, respectively as azaanalogues of isoerianin and isoCA-4. High inhibition of cell growth was observed with compounds 2b and 2m in a range of human cancer cells. These potent drugs also inhibited tubulin assembly with micromolar IC50 values. Cell cycle analysis of K562 and HCT116 cells treated with nanomolar concentrations of 2b and 2m indicated that cells were arrested at the G2/M phase. Moreover, 2b and 2m induced apoptosis in HCT116 cells and destroyed in vitro models of neovasculature at very low doses. Docking studies revealed that these compounds adopted an orientation similar to that of isoCA-4 in the colchicine binding-site of tubulin.
Experimental
General considerations
The compounds were all identified by usual physical methods, i.e. 1 H-NMR, 13 C-NMR, IR, MS. 1 (s, 1H), 3 .79 (s, 6H), 3 .76 (s, 3H). 13 
4.3.a. N-(3-Fluoro-4-methoxyphenyl)-3,4,5-trimethoxy-N-methylaniline 2b
By following the general procedure described above for 1a. 
4.3.b. N-(3-fluoro-4-methoxyphenyl)-3,4,5-trimethoxy-N-methylbenzenaminium chloride 2b.HCl
To a solution of 2b (97 mg; 1 mmol) in MeOH-Et2O (1:1) (10 mL) was added HClg within 10 min and then the mixture was stirred for 1h at RT. The precipitated salt 2b.HCl (92 mg; 86%) was isolated as green amorphous solid after filtration. 1 
3,4,5-Trimethoxy-N-(4-methoxy-3-nitrophenyl)-N-methylaniline 2c
4-Methoxy-N-methyl-N-(3,4,5-trimethoxyphenyl)benzene-1,3-diamine 2d
To a (EtOH/H2O: 4/1) solution (1.5 mL) of 2c (140 mg; 0.4 mmol) were added iron (225 mg; 4 mmol) and a drop of HCl 12N. After refluxing for 2 h, the mixture was filtered through a pad of Celite, concentrated to give a residue which was subjected to flash chromatography to give 2d as a brown oil (96 mg, 76%). 1 
N-Methyl-N-(3,4,5-trimethoxyphenyl)naphthalen-2-amine 2e
By following the general procedure described above for 1a. Hz), 7.46-7.42 (m, 2H), 7.36-7.22 (m, 2H), 6.45 (s, 2H) , 5 .86 (s, 1H), 3 .89 (s, 3H), 3 .84 (s, 6H). 13 C NMR (75 MHz, CDCl3) 153.9 (2), 141.4, 139.2, 134.7, 133.2, 129.2, 129.1, 127.7, 126.5, 126.5, 123.5, 119.9, 111.5, 96.4 (2) , 61. 
N-(3-(benzyloxy)-4-methoxyphenyl)-3,4,5-trimethoxy-N-methylaniline 2f
Compound 2f was prepared from diarylaniline 1e (yield 61%) according to literature [41] . 1 
AzaisoCA-4 2g
Compound 2g was prepared from diarylaniline 2f using H2 and Pd/C (10 mol%) in EtOAc (yield 98%) according to literature [41] . 1 Hz, J = 2.7 Hz), 6.14 (s, 2H), 5 .64 (s, 1H), 3 .87 (s, 3H), 3 .80 (s, 3H), 3 .77 (s, 6H), 3.22 (s, 3H). 13 
2-Methoxy-5-(methyl(3,4,5-trimethoxyphenyl)amino)phenyl acetate 2h
At 0° C, to a solution of 2g (101 mg; 0.316 mmol) in CH2Cl2 (1 mL) were added pyridine (54 L), and DMAP (0.016 mmol) and Ac2O (42 L). After one hour of stirring, H2O (3 mL) was added to the mixture. After extraction with EtOAc (3 x 3 mL), the organic layer was dried, evaporated, and the residue was subjected to flash chromatography to give 2h as a yellow oil (76 mg, 67%). 1 
N-(4-Chlorophenyl)-3,4,5-trimethoxy-N-methylaniline 2i
By following the general procedure described above for 1a. N,N,N'-Trimethyl-N'-(3,4,5-trimethoxyphenyl)benzene-1,4 
-diamine 2j
In a sealed tube and under an argon atmosphere were added successively, Pd2(dba) 3 
6-Methoxy-N-methyl-N-(3,4,5-trimethoxyphenyl)pyridin-3-amine 2k
By following the general procedure described above for 1a. Heating at 100°C 3.78 (s, 6H). 13 
N-Methyl-N-(3,4,5-trimethoxyphenyl)quinolin-3-amine 2l
N-Methyl-1-(phenylsulfonyl)-N-(3,4,5-trimethoxyphenyl)-1H-indol-5-amine 2p
By following the general procedure described above for 1i. 
N-(3-(benzyloxy)-4-methoxyphenyl)-3,4,5-trimethoxy-N-propylaniline 3a
To a diarylamine 1e (197 mg; 0.5 mmol) solution in DMF (5 mL) was added at 0° C, NaH (24 mg; 1 mmol), and 1bromopropane (122 mg; 1 mmol). The mixture was stirred at r.t. for 2 h, diluted in EtOAc (5 mL) and washed with Sheep brain tubulin was purified according to the method of Shelanski [42] by two cycles of assembly-disassembly and then diluted in the assembly buffer containing 0.1 M MES, 0.5 mM MgCl2, 1 mM EGTA, and 1 mM GTP, pH 6.6 to a final concentration around 2-3 mg/mL. Tubulin assembly was monitored by fluorescence according to reported procedure [43] using DAPI as fluorescent molecule. Assays were realized on 96-well plates prepared with Biomek NKMC and Biomek 3000 from Beckman Coulter and read at 37°C on Wallac Victor fluorimeter from Perkin Elmer.
The IC50 value of each compound was determined as the concentration required to decrease the maximum assembly rate of tubulin by 50% compared to the rate in the absence of compound. The IC50 values for all compounds were compared to the IC50 of isoCA-4 and isoerianin measured the same day under the same conditions.
Cell Cycle Analysis
Exponentially growing cancer cells (K562, HCT116) were incubated with tested compound or DMSO for 24 h. Cellcycle profiles were determined by flow cytometry on a FC500 flow cytometer (Beckman-Coulter, France) as described previously. [44] 
Apoptosis Assay
Apoptosis was measured by the Apo-one homogeneous caspase-3/7 assay (Promega Co, WI) according to the manufacturer's recommendations. Briefly, cells were subcultured on a 96-well plate with 5 × 10 4 cells/well in 100 μL medium. After 24 h of incubation, the medium in the 96-well plate was discarded and replaced with medium containing different concentrations of 2b and 2m (7.5, 15, 25 and 50 nM). The treated cells were incubated for 24 h, each well then received 100 μL of a mixture of caspase substrate and Apo-one caspase 3/7 buffer. After 1 h of incubation, the fluorescence of sample was measured using a Victor microtiter plate fluorimeter (Perkin-Elmer, USA) at 527 nm.
Inhibition of endothelial tube formation using ECFCs.
The protocol was achieved according to ref. [38] .
Cord Disruption Assay
HUVECs (2 × 10 4 cells per well) were plated in 96-well plates on a thick layer of Matrigel (Becton Dickinson; 10 mg mL -1 , 60 µL per well) and allowed to align for 24 h. 2b, 2m or vehicle (DMSO) were added to the formed cords and left for 3 h. Images were taken 3 h after the addition of compounds.
Molecular Modelling
Coordinates for compounds 2b, 2m and isoCA-4 were generated using CORINA v3.44 software. [45] Molecules were then freely docked in the colchicine binding site between chains C and D from PDB structure 1SA0 using GOLD v5.1 software. [46] CHEMPLP with default parameters was used as an objective function. [47] Structures of the complexes were exported for further examination and depiction with Chimera v1. 8 .1 software, [48] including hydrogen bonds detection, close contact analysis and representation of the solvent-accessible surface colored according to polarity.
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